期刊文献+

盆腔放疗患者院内泌尿系感染对策分析

Countermeasure analysis of urinary tract infection in hospital in Department of Pelvic Radiotherapy in a hospital
暂未订购
导出
摘要 目的:分析盆腔放疗患者院内泌尿系感染易感因素及控制对策。方法:选取2014年3月-2018年12月盆腔放疗住院患者4171例,分析泌尿系感染部位及易感因素。结果:4171例患者共发生感染141例,泌尿系统感染居首位(103例),留置导尿管、感染前48 h仍然留置双J管和感染时进行放疗为主要易感因素。结论:盆腔放疗科主要应重点防控院内泌尿系感染。 Objective:To explore the predisposing factors and control measures of urinary tract infection in hospital in patients with pelvic radiotherapy.Methods:From March 2014 to December 2018,4171 inpatients in Department of Pelvic Radiotherapy were selected,and we analyzed the location of urinary tract infection and the predisposing factors.Results:There were 141 cases of infection,and urinary system infection was the first(103 cases).Indwelling catheter,indwelling double J catheter at 48 hours before infection and radiotherapy in infection were the main susceptible factors.Conclusion:The Department of Pelvic Radiotherapy should focus on the prevention and control of urinary tract infection in the hospital.
作者 丘敏 湛承华 郑志坚 刘云 罗金锋 Qiu Min;Zhan Chenghua;Zheng Zhijian;Liu Yun;Luo Jinfeng(Department of Infection Management,the People's Hospital of Meizhou City,Guangdong Province,Guangdong,Meizhou 510310)
出处 《中国社区医师》 2020年第1期187-188,共2页 Chinese Community Doctors
关键词 盆腔放疗科 医院感染 泌尿系感染 Department of Pelvic Radiotherapy Nosocomial infection Urinary tract infection
  • 相关文献

参考文献4

二级参考文献27

  • 1林臻.恶性肿瘤患者放疗和(或)化疗后医院感染调查[J].广西医学院学报,2008,18(2):317-319. 被引量:12
  • 2高瑞英,盖红波.肿瘤放、化疗患者医院感染因素及对策[J].中华医院感染学杂志,2006,16(9):1041-1041. 被引量:19
  • 3Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015,65 ( 1 ) : 5-29. DOI : 10.3322/caac.21254.
  • 4Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2) : 115-132. DOI: 10.3322/ caae.21338.
  • 5Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phaseⅢ trial after a median follow-up of 11 years [J]. J Clin Oncol, 2012,30 (16) : 1926-1933. DOI : 10.1200/JC0.2011.40. 1836.
  • 6Sauer R, Becker H, Hohenberger W, et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J].N Engl J Med, 2004, 351 ( 17 ) : 1731 - 1740. DOI : 10.1056/NEJMoa040694.
  • 7Bosset JF, Calais G, Daban A, et al. Preoperative chemoradiotherapy vrtsus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of 22921 randomised trial conc|ucted by EORTC Radiotherapy Group [J]. Eur J Cancer, 2004,4-0(2) : 219-224.
  • 8Rodel C, Liersch T, Hermann RM, et al. Mutlicenter phase II trail of chemoradiation with oxaliplatin for rectal cancer [Jl. J Clin Oncol, 2007,25 ( 1 ) : 110-117. DOI: 10.1200/JC0.2006.08. 3675.
  • 9Bergquist JR, Thiels CA, Shubert CR, et al. Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study[J]. World J Surg, 2016, 40(2) :447-455. DOI: 10.1007/s00268-015-3319-7.
  • 10Lorehel F, Peignaux K, Cr6hange G, et al. Preoperative radiotherapy in elderly patients with rectal cancer [J]. Gastroenterol Clin Biol, 2007,31 (4):436-441. DOI:GCB-04- 2007-31-4-0399-8320-101019-200520014.

共引文献6583

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部